1. SARMs cycling - please answer per cycle and not accumulatively

The aim of this research is to analyse the effects of SARMs on various demographics. Each survey is intended to be filled out PER CYCLE and not as an overall experience. E.g. If over the last year you have run three separate cycles of "Ostarine", "Andarine" and then "Ostarine & LGD-4033" please fill out three separate surveys. 

This survey has been created based on the most common documented pieces of information available online. If a question fails to provide an answer you expected to see, please add a concise comment. 

* 1. Which SARM have you taken? (If you ran a cycle with two or more, select all that apply)

* 2. What average dosage did you take per day? (Please specify if you'd like to provide more accurate data. E.g. 5mg for first 2 weeks of cycle, then 10mg for 2 weeks and 25mg for last X number of weeks)

* 3. How long did you take these SARMs for?

* 4. Documented Benefits - did you notice any of the following? (Rate each and add a comment if a benefit hasn't been provided)

  No Improvement Slight Improvement Noticeable Improvement Considerable Improvement Significant Improvement
Improved Strength
Increased Mobility
Improved Overall Wellbeing
Improved Fat Loss
Improved Libido

* 5. Documented Side Effects - did you notice any of the following? (Add a comment if the side effect is not listed)

  Did Not Affect Me Slightly Noticeably Considerably  Significantly
Vision Impairment (including yellow tint, sensitivity to light or night blindness) 
Testosterone Suppression
Unwanted Hair
Water Retention
Low Libido

* 6. Did you require PCT? (Post Cycle Therapy)

* 7. Would you take SARMs again?

* 8. Did you get any blood analysed prior and post cycle? If so, provide any pre and post values (write "N/A" if this doesn't apply)

* 9. What (if anything) would you do differently next time? (Write "N/A" if you wouldn't change anything)

* 10. How old were you when you started this cycle?

* 11. What is your gender?

Page1 / 1
100% of survey complete.